Literature DB >> 2681416

Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor.

D F Zhou1, J F Ding, L J Picker, R F Bargatze, E C Butcher, D V Goeddel.   

Abstract

Mouse phagocytic glycoprotein-1 (Pgp-1; Ly-24) is a 95-kDa glycoprotein of unknown function that has served as an important T cell/leukocyte differentiation marker. Recent work has suggested that it may be related to a human 85- to 95-kDa glycoprotein (termed variously the Hermes Ag/lymphocyte homing receptor, ECMRIII, P80, and CD44) that is involved in lymphocyte binding to high endothelial venules in the process of lymphocyte homing, and has been implicated in other cell adhesion events. The widespread expression of this molecular class in diverse organ systems suggests a broad role in cellular adhesion, and has led to the unifying designation homing-cellular adhesion molecule (H-CAM). By using human H-CAM cDNA probes, we have isolated a full-length cDNA for the mouse homolog. Comparison of the human and mouse sequences reveals that an N-terminal domain homologous to cartilage proteoglycan core and link proteins, as well as the C-terminal transmembrane and cytoplasmic sequences, are highly conserved (89% and 86% identity, respectively). In contrast, a proximal extracellular domain thought to serve as a target for O-glycosylation and chondroitin sulfate attachment has undergone substantial divergence (only 42% identity). Transient expression of the cDNA in CHO cells followed by immunologic staining confirms that this mouse H-CAM cDNA encodes Pgp-1.1, one of two known Pgp-1 alloantigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681416

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Identification of a polymorphism in human CD44.

Authors:  H K Dadi; A M Greaves; D W Cox; M Letarte
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  Expression of CD44 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs.

Authors:  M Kasper; A Bierhaus; A Whyte; R M Binns; D Schuh; M Müller
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

Review 3.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  CD44 is not directly involved in the binding of lymphocytes to cultured high endothelial cells from peripheral lymph nodes.

Authors:  H Yang; R M Binns
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

5.  Splicing choice from ten variant exons establishes CD44 variability.

Authors:  C Tölg; M Hofmann; P Herrlich; H Ponta
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

6.  Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules.

Authors:  H Yang; R M Binns
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas.

Authors:  R G Hawley; M H Wang; A Z Fong; T S Hawley
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

Review 10.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.